Clinical trialNATerminated
Oncologic Impact of Splenectomy-omitting Radical Pancreatectomy in Well-selected Left-sided Pancreatic Cancer
- Outcome
- Stopped earlybecause of difficulties of enrolling appropriate participants (Enrollment)
- Phase
- NA
- Status
- Terminated
- Study type
- Interventional
- Start
- April 2013
- Expected end
- April 2014
- Enrollment
- 1 participants
- Sites
- 1
- Primary outcomes
- Bleeding amount
- Sponsor
- Other
- Results posted
- No
- Last update
- 22 November 2016
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
When distal pancreatectomy is carried out for left-sided pancreatic cancer, splenectomy is usually performed not only for margin-negative resection but also for effective clearance of the splenic hilar lymph nodes. However, there was no scientific evidence regarding the justifiability for spleen resection. Considering potential immunological function of the spleen, the investigators hypothesized that distal pancreatectomy without pancreatectomy for left-sided pancreatic cancer is superior than Distal pancreatectomy with pancreatectomy in terms of short-term perioperative outcomes and disease-specific overall survival.